Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;93(1-2):145-150.
doi: 10.1111/ans.18236. Epub 2022 Dec 29.

18-Fluoride fluorodeoxyglucose positron emission tomography is impactful in newly diagnosed pancreatic adenocarcinoma

Jack Power  1 , George Larcos  1   2
Affiliations

18-Fluoride fluorodeoxyglucose positron emission tomography is impactful in newly diagnosed pancreatic adenocarcinoma

Jack Power et al. ANZ J Surg. 2023 Jan.

Abstract

Background: Adenocarcinoma of the pancreas has a dismal prognosis. Surgical resection increases survival but is reliant on accurate detection and staging of disease. In overseas studies, 18 F-FDG positron emission tomography (PET) has been shown to have high diagnostic accuracy and staging utility, but local data remain sparse, in part because the technique has hitherto been unfunded via the Medicare benefits schedule. Although Commonwealth funding for rare tumours (including of the pancreas) has been recently approved to commence in late 2022, the proposed item descriptor wording implies that PET should lead to a significant change in management. Accordingly, the aims of this study are to characterize PET findings in newly diagnosed pancreatic adenocarcinoma using standard parameters, such as the SUVmax , and assess the proportion of cases in which PET altered initial management planning.

Methods: We analysed the PET findings of these cancers (presence and degree of metabolic activity in the primary lesion, as well as within malignant nodal and metastatic lesions) and compared the pre- and post-PET management plans of the referring specialists.

Results: Of 51 patients we found that (a) increasing SUVmax of the primary lesion correlated with an increase in disease stage (r-value = 0.335; P-value = 0.016), and (b) PET contributed to a significant change in management in 35% of patients.

Conclusion: In newly diagnosed pancreatic adenocarcinoma, parameters in PET correlate with disease stage and the overall findings contribute to a significant management change in about 35% of patients.

Keywords: adenocarcinoma; pancreas; positron emission tomography; prognosis.

PubMed Disclaimer

References

    1. Hillner B, Siegel B, Shields A et al. Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry. J. Nucl. Med. 2008; 49: 1928-35.
    1. Kubota K, Matsuno S, Morioka N et al. Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer. Ann. Nucl. Med. 2015; 29: 431-41.
    1. Scarsbrook A, Barrington S. PET-CT in the UK: current status and future directions. Clin. Radiol. 2016; 71: 673-90.
    1. Scott A, Gunawardana D, Kelley B et al. PET changes management and improves prognostic stratification in patients with recurrent colorectal cancer: results of a multicenter prospective study. J. Nucl. Med. 2008; 49: 1451-7.
    1. Scott A, Gunawardana D, Bartholomeusz D, Ramshaw J, Lin P. PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study. J. Nucl. Med. 2008; 49: 1593-600.

LinkOut - more resources